Antihypertensive Drug Treatment and the Risk for Intrahemodialysis Hypotension

Clin J Am Soc Nephrol. 2024 Jul 16. doi: 10.2215/CJN.0000000000000521. Online ahead of print.

Carmine Zoccali^{1

2

3}, Giovanni Tripepi⁴, Paola Carioni⁵, Edouard L Fu⁶, Friedo Dekker⁷, Vianda Stel^{8

9}, Kitty J Jager^{8

9}, Francesca Mallamaci^{4

10}, Jeffrey L Hymes¹¹, Franklin W Maddux¹¹, Stefano Stuard¹²

¹ Renal Research Institute, New York, New York.
² Institute of Molecular Biology and Genetics (Biogem), Ariano Irpino, Italy.
³ Associazione Ipertensione Nefrologia Trapianto Renale (IPNET), c/o Nefrologia, Grande Ospedale Metropolitano, Reggio Calabria, Italy.
⁴ CNR-IFC, Institute of Clinical Physiology, Research Unit of Clinical Epidemiology, Reggio Calabria, Italy.
⁵ Fresenius Medical Care, Global Medical Office, Crema, Italy.
⁶ Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
⁷ Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
⁸ Department of Medical Informatics, ERA Registry, Amsterdam UMC location and the University of Amsterdam, Amsterdam, The Netherlands.
⁹ Quality of Care, Amsterdam Public Health, Amsterdam, The Netherlands.
¹⁰ Nephrology, Dialysis and Transplantation Unit, Azienda Ospedaliera "Bianchi-Melacrino-Morelli" Grande Ospedale Metropolitano of Reggio Calabria, Reggio Calabria, Italy.
¹¹ Fresenius Medical Care, Global Medical Office, Waltham, Massachusetts.
¹² Fresenius Medical Care, Global Medical Office, Bad Homburg, Germany.

No abstract available